Currently Viewing:
The Academy of Managed Care Pharmacy (AMCP) Nexus 2018
Drug Market to See More Competition, Launch of Biosimilars in 2019
October 23, 2018
Dr Aimee Tharaldson Outlines Current Key Market Trends in Specialty Pharmacy
October 23, 2018
Dr Jane F. Barlow: How Curative, High-Cost Therapies Bring Challenges to the Reimbursement Landscape
October 23, 2018
Law to Curb Opioid Abuse Will Have Many Managed Care Priorities, Experts Say
October 23, 2018
Analysis Finds HIV Therapy Biktarvy Associated With Cost Savings Compared With Most Regimens
October 24, 2018
Dr Christopher Diehl Explains the Pharmacist's Role in Value-Based Models
October 24, 2018
Dr Jennifer Graff on Using Real-World Evidence to Deliver High-Quality Care
October 24, 2018
CMS Audits Give View Into How Well Health Plans Deliver Medicare Programs
October 24, 2018
Massachusetts Medicaid Finds CAR T-Cell Payment Solution While Waiting on CMS
October 25, 2018
Currently Reading
Dan Mendelson: Healthcare Policy Changes Avalere Health Is Paying Attention To
October 25, 2018
From Pathways to Pharmacy: Sharing Approaches to Value-Based Care
October 25, 2018
Dr Jane F. Barlow on How Curative, High-Cost Therapies Will Affect Patient OOP Costs
November 09, 2018
Dr Aimee Tharaldson: Recently Approved Specialty Drugs, Upcoming Approvals to Watch For
November 13, 2018
Dan Mendelson Discusses How Mergers and Acquisitions Are Affecting the Market
November 14, 2018
Dan Mendelson on the Trump Administration's Efforts to Lower Drug Prices
November 22, 2018
Dr Jane F. Barlow Discusses Potential New Reimbursement Models for New, High-Cost Therapies
November 27, 2018
Dan Mendelson's Expectations for Cross-Sector Mergers Like CVS, Aetna
November 28, 2018
Specialty Drug Approvals Dr Aimee Tharaldson is Looking Out for in 2019
November 29, 2018
Dan Mendelson on the Shift to Value-Based Care and Prescribing Patterns
December 22, 2018

Dan Mendelson: Healthcare Policy Changes Avalere Health Is Paying Attention To

Dan Mendelson, MPP, founder, Avalere Health, outlines the impact recent healthcare policy changes have on pharmacists and providers.

Dan Mendelson, MPP, founder, Avalere Health, outlines what recent healthcare policy changes Avalere Health is paying the most attention to.


What recent healthcare policy changes has Avalere Health been paying the most attention to?

This is a really vibrant and rapidly changing environment, and I think it’s important for pharmacists to understand that they are really living in a context of a lot of change. A lot of the change is focused around the health plan world. So, health plans today are increasingly being asked to take risk, to improve quality for patients, and really to start to integrate some of the pharmacy offerings into the medical aspects of the offerings. So, the plan environment is changing rapidly, quality measures are really driving a lot of the activity in plans, and that’s kind of the first major piece that’s of relevance.

Second, I’d say that in the provider world, a lot of those incentives that the plans are under are now trickling down into the provider space. I mean, providers know that they are not going to be the one to immunize the patient, they’re not going to be the ones to hand them their medication. So, the plans know that, and the providers ultimately need to be aligned into the kinds of incentives that exist in that context. So, that’s another aspect.

I’d say also that the individual markets are important for pharmacists. The reality is that the individual markets are small as a percentage of total markets but are driving a lot of the trends that we are seeing: high-deductible health plans, restrictive networks, and the like. So, those are some of the things we’re most focused on, and I think kind of speak to the importance of understanding the change environment.

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up